3Hirai, AzumaT, ItoS, et al. A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylor[J].Gaslroenterol, 1995,30 (4) : 461 - 464.
4Park J B, Imamura L, Kobashi K. Kinetic studies of helieobaeter bylori urease inhibition by a novel proton pump inhibitor, rabeprazole[J]. Biol Pharm Bull, 1996 19(2) : 182 - 187.
二级参考文献2
1Malfertheiner P, Megraud F, O′Morain C, et al. European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther,2002 ,16:167-180.
6Hirai M, Azuma T, Ito S, et al.A proton pump inhibitor, E3810, has antibacterial activity through binding toHelicobacter pylori[J]. Journal of Gastroenterology, 1995, 30 ( 4 ) : 461-464.
7Park J B, Imamura L, Kobashi K.Kinectic studies of helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole[J].Biol Pharm Bull, 1996, 19 ( 2 ) : 182-187.
